Ryan J. Selhorn - Nov 11, 2024 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Chief Financial Officer
Signature
/s/ Ryan J. Selhorn
Stock symbol
AYTU
Transactions as of
Nov 11, 2024
Transactions value $
$0
Form type
4
Date filed
11/13/2024, 04:10 PM
Next filing
Mar 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AYTU Common Shares Award $0 +14K +738.79% $0.00 15.9K Nov 11, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of restricted stock which vest as follows: One-third on November 11, 2025; 1/12th of the original grant quarterly thereafter through November 11, 2027.